Greifswald, Germany
Greifswald, Germany

Time filter

Source Type

This 225 pages market report, from Stratview Research, studies the global cold plasma market over the period 2011 to 2022. The report provides detailed insights on the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market. As per Stratview Research, the global cold plasma market offers an impressive CAGR of 12.2% during the forecast period of 2017 to 2022 and reach US$ 2,536 million in 2022, which offers an opportunity to the industry players to align themselves with the market growth. There are several factors bolstering the growth of global cold plasma market. The author of the report cited continuous innovations in cold plasma technology, rising demand for eco-friendly products, increasing use of cold plasma in food packaging industry, introduction of stringent safety standards in various industries including food safety, and growing needs for frozen food as some of the growth drivers of the cold plasma market. Electrical & electronic industry is forecasted to remain the largest segment of cold plasma over the next five years, driven by its increasing preference in semiconductors. The food industry is projected to witness the highest growth during the same period, driven by increased safety standards with higher demand for non-hazardous plasmas. Register Here for a Free Sample of the 225 Pages Report In terms of application type, cleaning & activation is projected to remain the largest application of cold plasma during the forecast period, propelled by an increasing penetration in the electrical & electronic and polymer & plastics industries. Decontamination currently holds a diminutive share in the global cold plasma market but is expected to witness the highest growth during the forecast period, driven by the food industry. As per the study, both low and atmospheric pressure cold plasmas are projected to grow at impressive rates over the next five years. In terms of region, Europe is projected to remain the largest market for cold plasma during the forecast period, driven by the presence of several cold plasma suppliers and high research & development activities in the major European markets. However, Asia-Pacific is projected to witness the highest growth during the same period driven by the continuous shift of electronic manufacturing to Asia countries, increasing demand for decontaminated frozen food, growing manufacturing facilities of textiles, and increasing production of polymers. Global cold plasma market is highly fragmented with the presence of few global players and several small regional players. ADTEC Plasma Technology Co. Ltd., Enercon Industries Corporation, Europlasma NV, Henniker Plasma, Neoplas Tools GmbH, Nordson Corporation, P2i Limited, Plasmatreat GmbH, Tantec A/S, and Vetaphone A/S are major players in the global cold plasma market. Development of new applications, innovations in new technology, and collaboration with customers are some of the key strategies adopted by major companies to gain a competitive edge over the others. This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report: This report studies global cold plasma market and has segmented the market in four ways, keeping in mind the interest of all the stakeholders across the value chain. The following are the four ways in which the market is segmented: The global cold plasma market is segmented into the following categories: Stratview Research has several high value market reports in the chemicals and materials industry. Please refer to the following link to browse through our reports: Click Here for Other Reports from Stratview Research in the Chemicals & Materials Industry Related premium market reports in the advanced materials industry are: Global High Performance Glass Fiber Market by End Use Industry, by Usage, and by Region, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2016 - 2021 Global Composite Preforms Market by Application Segment, by Fiber Type, by Product Type, by Structure Type, and by Region, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2016 - 2021 Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. We have a strong team of industry veterans and analysts with an extensive experience in executing custom research projects for mid-sized to Fortune 500 companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, Go to Market Strategy, and Voice of Customer studies. Stratview Research is a trusted brand globally, providing high quality research and strategic insights that help companies worldwide in effective decision making. Please feel free to drop an enquiry with us or ask for a free sample in the below page and our team will get back to you very soon:


This 225 pages market report, from Stratview Research, studies the global cold plasma market over the period 2011 to 2022. The report provides detailed insights on the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market. As per Stratview Research, the global cold plasma market offers an impressive CAGR of 12.2% during the forecast period of 2017 to 2022 and reach US$ 2,536 million in 2022, which offers an opportunity to the industry players to align themselves with the market growth. There are several factors bolstering the growth of global cold plasma market. The author of the report cited continuous innovations in cold plasma technology, rising demand for eco-friendly products, increasing use of cold plasma in food packaging industry, introduction of stringent safety standards in various industries including food safety, and growing needs for frozen food as some of the growth drivers of the cold plasma market. Electrical & electronic industry is forecasted to remain the largest segment of cold plasma over the next five years, driven by its increasing preference in semiconductors. The food industry is projected to witness the highest growth during the same period, driven by increased safety standards with higher demand for non-hazardous plasmas. Register Here for a Free Sample of the 225 Pages Report In terms of application type, cleaning & activation is projected to remain the largest application of cold plasma during the forecast period, propelled by an increasing penetration in the electrical & electronic and polymer & plastics industries. Decontamination currently holds a diminutive share in the global cold plasma market but is expected to witness the highest growth during the forecast period, driven by the food industry. As per the study, both low and atmospheric pressure cold plasmas are projected to grow at impressive rates over the next five years. In terms of region, Europe is projected to remain the largest market for cold plasma during the forecast period, driven by the presence of several cold plasma suppliers and high research & development activities in the major European markets. However, Asia-Pacific is projected to witness the highest growth during the same period driven by the continuous shift of electronic manufacturing to Asia countries, increasing demand for decontaminated frozen food, growing manufacturing facilities of textiles, and increasing production of polymers. Global cold plasma market is highly fragmented with the presence of few global players and several small regional players. ADTEC Plasma Technology Co. Ltd., Enercon Industries Corporation, Europlasma NV, Henniker Plasma, Neoplas Tools GmbH, Nordson Corporation, P2i Limited, Plasmatreat GmbH, Tantec A/S, and Vetaphone A/S are major players in the global cold plasma market. Development of new applications, innovations in new technology, and collaboration with customers are some of the key strategies adopted by major companies to gain a competitive edge over the others. This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report: This report studies global cold plasma market and has segmented the market in four ways, keeping in mind the interest of all the stakeholders across the value chain. The following are the four ways in which the market is segmented: The global cold plasma market is segmented into the following categories: Stratview Research has several high value market reports in the chemicals and materials industry. Please refer to the following link to browse through our reports: Click Here for Other Reports from Stratview Research in the Chemicals & Materials Industry Related premium market reports in the advanced materials industry are: Global High Performance Glass Fiber Market by End Use Industry, by Usage, and by Region, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2016 - 2021 Global Composite Preforms Market by Application Segment, by Fiber Type, by Product Type, by Structure Type, and by Region, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2016 - 2021 Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. We have a strong team of industry veterans and analysts with an extensive experience in executing custom research projects for mid-sized to Fortune 500 companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, Go to Market Strategy, and Voice of Customer studies. Stratview Research is a trusted brand globally, providing high quality research and strategic insights that help companies worldwide in effective decision making. Please feel free to drop an enquiry with us or ask for a free sample in the below page and our team will get back to you very soon:


Grant
Agency: European Commission | Branch: FP7 | Program: CP-FP | Phase: HEALTH.2010.2.4.2-1 | Award Amount: 7.98M | Year: 2010

According to the European Society of Cardiology there has been an increase in the life expectancy at the age of 65 of the European population from 15.0 to 17.0 years in the years since 1980. In the elderly, up to 50% of deaths are caused by cardiovascular diseases, the majority accounted for by coronary artery disease. The most effective treatment for obstructive coronary disease is percutaneous intervention with coronary stenting and fuelled by the increasing disease burden there has been a rapid increase in the number of percutaneous coronary intervention procedures in Europe from 184,000 in 1992 to 885,000 in 2004. If the rate of progression remains constant, the projected number of coronary intervention procedures per annum will be about 1.5 million by 2010, with a stenting rate of close to 100%. The principal safety issue with current coronary stenting procedures is late stent thrombosis which, with a case mortality rate approaching 50%, makes this problem a very significant European health issue. The PRESTIGE project will result in significant improvement in prediction and prevention of late stent thrombosis by providing novel strategies that causally impede incident events without increasing the overall risk of bleeding. These goals will be achieved by a multidisciplinary consortium formed by world-leading EU-based specialists covering the requisite scientific skills and experience. Since the first drug-eluting stent was introduced in 2002 the growth of this sector has been explosive. Forecasts predicted the potential for this market segment to exceed 4.6 billion by 2009. The economic impact of this very ambitious project will be to provide the European health industries with novel stent products and new imaging technologies to identify patients at-risk, as well as amended European treatment guidelines. The social impact will be, amongst others, a tremendous cost reduction for the public and private health insurance systems all over Europe.


Vorhaben T.,University of Greifswald | Bottcher D.,University of Greifswald | Jasinski D.,Neoplas GmbH | Menyes U.,Neoplas GmbH | And 4 more authors.
ChemCatChem | Year: 2010

In this work, the immobilization of two hydrolases on plasma-modified polypropylene carriers was investigated. Treating Accurel MP1001 with an oxygen plasma was found most suitable to increase the hydrophilicity and to allow for efficient immobilization. Thus, for lipase B from Candida antarctica and for an esterase from Pyrobaculum calidifontis esterase (PestE) a 5-fold and 14-fold increase, respectively, in immobilization yield resulted compared to untreated carrier. In contrast to the oxygen-modified support, modification of the polypropylene carrier with ammonia plasma showed no positive effect. Furthermore, it could be shown that immobilized PestE catalyzed enantioselective transesterification of α-phenylethanol in vinyl acetate, whereas the free enzyme showed no activity. Both hydrolases could be recycled five times without significant loss of activity. © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.


Mallin H.,University of Greifswald | Menyes U.,Enzymicals AG | Vorhaben T.,Neoplas GmbH | Hohne M.,University of Greifswald | Bornscheuer U.T.,University of Greifswald
ChemCatChem | Year: 2013

Two (R)-selective amine transaminases from Gibberella zeae (GibZea) and from Neosartorya fischeri (NeoFis) were immobilized on chitosan as a carrier to improve their application in the biocatalytic synthesis of chiral (R)-amines. An (S)-selective enzyme from Vibrio fluvialis (VfTA) was used for comparison. After improving the immobilization conditions, all enzymes could be efficiently immobilized. Additionally, the thermal stability of GibZea and NeoFis could be improved and also a slight shift of the pH optimum was observed for GibZea. All enzymes showed good activity in the conversion of α-methylbenzylamine. In the asymmetric synthesis of (R)-2-aminohexane from the corresponding ketone, a 13.4-fold higher conversion (>99%) was found for the immobilized GibZea compared to the free enzyme. Hence, the covalent binding with glutaraldehyde of these enzymes on chitosan beads resulted in a significant stabilization of the amine transaminases investigated. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.


Bussiahn R.,Leibniz Institute Fur Plasmaforschung Und Technology E.V. | Bussiahn R.,Neoplas GmbH | Lembke N.,Neoplas GmbH | Gesche R.,Ferdinand - Braun - Institute | And 2 more authors.
Hygiene + Medizin | Year: 2013

Physical plasmas applied to biological materials give cause for interdisciplinary research and open up new therapeutic options in medicine. Basic research aims for clarifying the interaction between plasma and living tissue or organisms. Direct therapeutic application in dentistry and dermatology like wound healing or treatment of skin diseases are of highest interest. This requires cold and tissue-tolerable plasma. In recent years, very different plasma source concepts had been developed and tested for their practicability. Their basic characterization in terms of electrical and thermal properties as well as spectral emission and production of chemical reactive species is a precondition for risk assessment and evaluation of possible fields of application. In the following, two examples of such plasma sources are introduced.


Kawai Y.,Kyushu University | Uchino K.,Kyushu University | Muta H.,Kyushu University | Kawai S.,Japan National Institute of Advanced Industrial Science and Technology | Rowf T.,Neoplas GmbH
Vacuum | Year: 2010

To develop ECR plasma source for industrial applications, we produced a large diameter ECR plasma and examined radial profiles of the ion saturation current as a function of pressure and power. It was found that ECR plasma uniform over 300 mm is produced for pressures higher than 1 mTorr and the electron temperature decreases with increasing pressures. © 2010 Elsevier Ltd. All rights reserved.


Patent
Leibniz Institute for Plasma Science, Technology and Neoplas Gmbh | Date: 2015-06-05

The invention relates to a device, preferably a collar, for treating areas of human or animal skin or mucous membrane with a cold atmospheric pressure plasma by creating a dielectrically hindered surface discharge, comprising at least one flexible insulating material (1), a flexible high-voltage electrode (2), a flexible dielectric (3), a flexible grounded electrode (4) and a gas supply (7), characterized in that the flexible high-voltage electrode (2) is embedded in the insulating elastomer (3), having the effect of a dielectric, and the grounded electrode (4) is applied to the elastomer surface facing the surface to be treated.


Patent
Neoplas Gmbh | Date: 2010-02-12

A method and a series of devices for dry cleaning, activating, modifying, coating, and biologically decontaminating (degerming, disinfecting, sterilizing) surfaces by means of an atmospheric pressure plasma generated using a surface barrier discharge are provided. The invention is used for dry cleaning, activating, coating, modifying, and biologically contaminating surfaces by means of an atmospheric pressure plasma generated in a defined, flowing gas atmosphere by a surface barrier discharge, comprising a high-voltage electrode that is covered with a dielectric or ferroelectric material, an electrically conducting grounded contact electrode, a high-voltage supply, a gas supply, and a gas nozzle (encompassing a gas outlet); said gas nozzle is located in the direct vicinity of the grounded contact electrode, is integrated into the contact electrode, or acts as the grounded contact electrode.


Patent
NEOPLAS GmbH, Leibniz Institute for Plasma Science and Technology | Date: 2010-07-27

The invention relates to a device, preferably a collar, for treating areas of human or animal skin or mucous membrane with a cold atmospheric pressure plasma by creating a dielectrically hindered surface discharge, comprising at least one flexible insulating material (1), a flexible high-voltage electrode (2), a flexible dielectric (3), a flexible grounded electrode (4) and a gas supply (7), characterized in that the flexible high-voltage electrode (2) is embedded in the insulating elastomer (3), having the effect of a dielectric, and the grounded electrode (4) is applied to the elastomer surface facing the surface to be treated.

Loading Neoplas GmbH collaborators
Loading Neoplas GmbH collaborators